NP33923 Ranibizumab

A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
£5M
Sector
HEALTH
Published
27 Jul 2023
Delivery
not specified
Deadline
n/a

Concepts

Location

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014

Geochart for 1 buyers and 4 suppliers

1 buyer

4 suppliers

Description

Supply of ranibizumab injections to NHS Scotland

Total Quantity or Scope

Supply of ranibizumab 1.65mg/0.165ml solution for injection pre-filled syringes and ranibizumab 2.3mg/0.23ml solution for injection vials to NHS Scotland. This has been awarded as an unranked multi supplier framework agreement.

Award Detail

1 Teva (Castleford)
  • Reference: 021851-2023-1
  • Value: £5,422,720 [share]
  • Awarded to group of suppliers.
2 Biogen Idec (Maidenhead)
  • Reference: 021851-2023-1
  • Value: £5,422,720 [share]
  • Awarded to group of suppliers.
3 Thornton & Ross (Huddersfield)
  • Reference: 021851-2023-1
  • Value: £5,422,720 [share]
  • Awarded to group of suppliers.
4 Novartis Pharmaceuticals (Frimley)
  • Reference: 021851-2023-1
  • Value: £5,422,720 [share]
  • Awarded to group of suppliers.

Award Criteria

Supply Chain 5
price 95

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value referred to in Section II.1.7 and V.2.4 covers the twelve (12) month initial duration and the thirty six (36) month extension period of the framework agreement. (SC Ref:739925)

Reference

Domains